Video Experimental Relacionado
Updated: Jun 10, 2026
04:41
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 15, 2010
Un ensamblaje específico de proteína beta amiloide en el cerebro perjudica la memoria
Sylvain Lesné1, Ming Teng Koh, Linda Kotilinek
1Department of Neurology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.
Nature
|March 17, 2006
Resumen
Un conjunto de beta amiloide soluble, denominado Abeta * 56, causa pérdida de memoria en ratones envejecidos antes de que se formen placas. Este hallazgo sugiere que Abeta*56 puede ser un conductor temprano del deterioro cognitivo en la enfermedad de Alzheimer.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Investigación sobre el envejecimiento Investigación sobre el envejecimiento.
- Biología Molecular Biología Molecular
Sus antecedentes:
- El deterioro de la memoria relacionado con la edad a menudo está relacionado con cambios sinápticos, que preceden a la pérdida neuronal.
- La enfermedad de Alzheimer implica neurodegeneración y placas amiloides, pero los déficits tempranos de memoria pueden ocurrir sin ellas.
- Tg2576 ratón modelo de la enfermedad de Alzheimer mediante la expresión de una proteína precursora amiloide humana (APP) variante.
Objetivo del estudio:
- Investigar la causa del deterioro de la memoria en ratones Tg2576 que carecen de neurodegeneración o amiloidosis.
- Identificar las especies moleculares específicas responsables de los déficits tempranos de la memoria.
- Determinar si los conjuntos de beta amiloide solubles preceden a la formación de placas y el deterioro cognitivo.
Principales métodos:
- Utilizó el modelo de ratón Tg2576 en diferentes puntos de edad (jóvenes, de mediana edad, viejos).
- Evaluar la función de la memoria en relación con la neuropatología (pérdida neuronal, placas amiloides).
- Conjuntos de beta amiloide soluble aislados y caracterizados, específicamente Abeta*56.
- Probó los efectos perturbadores de la memoria de Abeta*56 purificado en ratas jóvenes.
Principales resultados:
- Los ratones de mediana edad Tg2576 exhibieron déficits de memoria sin pérdida de neuronas o formación de placa significativa.
- Un ensamblaje de beta amiloide soluble de 56 kDa (Abeta*56) fue identificado como la especie acumulante en ratones afectados.
- La administración de Abeta*56 purificado a ratas jóvenes indujo deterioro de la memoria.
- La acumulación de Abeta*56 se correlacionó con déficits de memoria independientemente de la neuropatología establecida.
Conclusiones:
- Abeta*56 es un factor clave que causa déficits de memoria en ratones Tg2576 que envejecen.
- Esta especie soluble de beta amiloide afecta la memoria antes de la formación de placa y la pérdida neuronal.
- Abeta*56 representa un objetivo terapéutico temprano potencial para los déficits cognitivos en la enfermedad de Alzheimer.
Más Videos Relacionados
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
06:23Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
Videos de Conceptos Relacionados
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...